MAVENCLAD
Live / Registered — Registered — international registration renewed (as of 26 Mar 2024)
What this means for you
Registered since 01 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79202778
- Registration number
- 5253420
- Mark type
- Stylized text
- Filed
- 18 Jan 2017
- Published for opposition
- 16 May 2017
- Registered
- 01 Aug 2017
- Attorney of record
- William C. Wright
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders
Owner
- Merck KGaA, DE
- Merck KGaA, DE
- Merck KGaA, DE
Prosecution history
- 26 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 26 Mar 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 25 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jul 2023 — TEAS SECTION 71 & 15 RECEIVED
- 01 Aug 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 08 Dec 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Nov 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Nov 2017 — FINAL DISPOSITION PROCESSED
- 01 Nov 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 16 May 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 May 2017 — PUBLISHED FOR OPPOSITION
- 26 Apr 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Apr 2017 — REFUSAL PROCESSED BY IB
- 04 Apr 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER